A lot of people around the world are the victims of Type 1 diabetes. A new research unveils the effectiveness of the omega-3 fatty acids to treat this autoimmune disorder.

Type 1 diabetes engulfs many people every year, only in the United States, the number has already crossed 1.25 million, according to Medical News Today. The key reason behind this health disorder is the gradual decrement of insulin. Victims of this disease can't recover as the immune systems of their bodies fail to identify the beta cells that create insulin and destroy them.

Glucose plays the significant role to create energy in the body and Insulin transports the glucose into the cells to perform that job. Now the death of the beta cells hampers the production of insulin and forces the glucose to store up in the blood. As a result, the immune system of the body gradually perishes with the decrement of energy. So far no proper solution to cure the type 1 diabetes is recovered.

The best option to treat the type 1 diabetes is the use of insulin injections, but it can't be the ultimate answer to recovery. The need of the hour is to protect the beta cells to produce insulin normally in the body. A recent investigation discovers the benefits of the omega-3 fatty acids in this regard. The complete research study is available in The Journal of Clinical Investigation.

Omega -3 fatty acids or the omega-3s are identified as the PUFAs or the polyunsaturated fatty acids. Seafood, fish, vegetable oils are the best source of this fatty acid. Omega-3s provide several health benefits, like addressing cardiovascular problems and others. Now the million dollar question is how this fatty acid plays an effective role in treating the type 1 diabetes.

Allan Zhao from the Guangdong University of Technology in China noticed that the omega-3 fatty acids recovered a human body from inflammatory processes. This feature inspired him to carry on a thorough research and to discover a way to treat the type 1 diabetes. Zhao and his team performed a test using the non-obese diabetic mice.

The researchers provided regular and PUFAs enriched diet and performed a genetic modification to increase the level of the omega-3s in the mice. The research team monitored the glucose and insulin tolerance of the mice after every three months. The team also collected the blood samples to measure the existing amount of serum insulin in the mice. The aim of the study was to see the impact of fatty acids to avail a clear idea in treating the type 1 diabetes.

All monitoring results revealed an effective improvement in the glucose metabolism and the decrement of the type 1 diabetes incidence. The test result also included the regeneration of the beta cells by the omega-3 fatty acids in the mice. The research study unveils a set of new dimensions in the arena of medical treatment.

The outcome of the research study proves the ability of the omega-3 fatty acids to treat the type 1 diabetes. Like other research works this research study also needs a minute and careful observation while conducting the human trials. It is an obvious fact that this new discovery brings new hope for those patients who are the victims of this autoimmune disorder.